The funding will support the launch of the VERITAS trial while strengthening the company's clinical and regulatory ...

Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.

Field Medical has generated another $35 million in venture capital funding for its cardiac pulsed field ablation system to support the launch of a pivotal trial. | The series B financing comes quickly ...

Scientist and teacher releases book summarizing his field of research from the last 25 years BALTIMORE, Nov. 4, 2024 /PRNewswire-PRWeb/ -- Author Victor Frenkel, PhD, has published his new popular ...

Researchers have developed a gene therapy technology that uses magnetic fields to switch groups of neurons on and off, controlling brain circuits affected by Parkinson’s disease. In addition to ...

--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis ...

Javid A, Biswas R, Ilham S, Chukwu C, Yang Y, Chen H, and Kiani M. A modular 16-channel high-voltage ultrasound phased array system for therapeutic medical applications. Neuroelectronics 2024(1):0004, ...

Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation ...

In the interdisciplinary field of medicine and materials science, a recent breakthrough by Professor Jianlin Shi's team is revolutionizing antibacterial therapy. They have successfully developed a ...

Detailed price information for Helius Medical Technologies Inc (HSDT-Q) from The Globe and Mail including charting and trades.